Literature DB >> 2626803

The beige mouse model for Mycobacterium avium complex (MAC) disease: optimal conditions for the host and parasite.

P R Gangadharam1, V K Perumal, D C Farhi, J LaBrecque.   

Abstract

We extended our earlier studies to establish the beige (C57B1/6/bgJ/bgJ) mouse model for experimental acute infections with Mycobacterium avium complex (MAC). Optimal conditions of the host and the parasites have been determined. Mice bred at our center showed similar responses to those obtained from Jackson Laboratories, the original supplier. Both male and female mice showed similar responses, but older mice in both sexes showed less susceptibility than younger mice. Strain 101 of MAC showed remarkable consistency in its pathogenicity to beige mice, as evidenced by the distribution of colony forming unit (CFU) counts at various time points after intravenous challenge, in several experiments. CFU counts showed an association with the dose of challenge, and histopathological observations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2626803     DOI: 10.1016/0041-3879(89)90020-2

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  9 in total

1.  Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection.

Authors:  Jean-Philippe Lanoix; Cédric Joseph; François Peltier; Sandrine Castelain; Claire Andréjak
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

2.  Evidence for a reduced chemokine response in the lungs of beige mice infected with Mycobacterium avium.

Authors:  M Florido; R Appelberg; I M Orme; A M Cooper
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.

Authors:  Claire Andréjak; Deepak V Almeida; Sandeep Tyagi; Paul J Converse; Nicole C Ammerman; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

Review 4.  Beige mouse model for Mycobacterium avium complex disease.

Authors:  P R Gangadharam
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

5.  Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice.

Authors:  H Tomioka; H Saito; K Sato; T Yamane; K Yamashita; K Hosoe; K Fujii; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

6.  Susceptibility of beige mice to Mycobacterium avium: role of neutrophils.

Authors:  R Appelberg; A G Castro; S Gomes; J Pedrosa; M T Silva
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits.

Authors:  M Emori; H Saito; K Sato; H Tomioka; T Setogawa; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice.

Authors:  K V Harshan; P R Gangadharam
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

Review 9.  Mycobacterium abscessus: It's Complex.

Authors:  Hazem F M Abdelaal; Edward D Chan; Lisa Young; Susan L Baldwin; Rhea N Coler
Journal:  Microorganisms       Date:  2022-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.